Financhill
Buy
69

STOK Quote, Financials, Valuation and Earnings

Last price:
$34.30
Seasonality move :
1.4%
Day range:
$30.17 - $35.34
52-week range:
$5.35 - $38.69
Dividend yield:
0%
P/E ratio:
51.75x
P/S ratio:
9.69x
P/B ratio:
6.33x
Volume:
1.8M
Avg. volume:
1.1M
1-year change:
157.54%
Market cap:
$2B
Revenue:
$36.6M
EPS (TTM):
$0.66

Earnings Data

Next earnings date for STOK
Mar 24
2026
Most recent earnings per share
-$0.65
Missed by $0.08
(Nov 4/2025)
Consensus Estimate
-$0.57
(Nov 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

STOK Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/24/2026 Q4 $5.1M -- -- -$0.72 --
11/04/2025 Q3 $6.2M $10.6M -$0.65 -$0.57 -$0.08
08/12/2025 Q2 $5.2M $13.8M -$0.40 -$0.54 $0.13
05/06/2025 Q1 $31.5M $158.6M $1.90 -$0.09 $1.99
03/18/2025 Q4 $4.3M $22.6M -$0.18 -$0.53 $0.35
11/05/2024 Q3 $3.6M $4.9M -$0.47 -$0.54 $0.07
08/07/2024 Q2 $3.3M $4.8M -$0.46 -$0.56 $0.10
05/06/2024 Q1 $3.2M $4.2M -$0.57 -$0.61 $0.04
03/25/2024 Q4 $3.2M $2.8M -$0.60 -$0.63 $0.03
11/07/2023 Q3 $3.2M $3.3M -$0.55 -$0.65 $0.09
08/07/2023 Q2 -- -$2.5M -$0.69 -- --
05/04/2023 Q1 -- $5.2M -$0.53 -- --
03/10/2023 Q4 -- $3.3M -$0.65 -- --
11/14/2022 Q3 -- $2.9M -$0.66 -- --
08/08/2022 Q2 -- $3.2M -$0.63 -- --
05/10/2022 Q1 -- $3M -$0.66 -- --
03/10/2022 Q4 -- -- -$0.66 -- --
11/08/2021 Q3 -- -- -$0.61 -- --
08/10/2021 Q2 -- -- -$0.60 -- --
05/10/2021 Q1 -- -- -$0.46 -- --
03/09/2021 Q4 -- -- -$0.42 -- --
11/12/2020 Q3 -- -- -$0.41 -- --
08/10/2020 Q2 -- -- -$0.39 -- --
05/15/2020 Q1 -- -- -$0.34 -- --
03/23/2020 Q4 -- -- -$0.31 -- --
11/12/2019 Q3 -- -- -$0.26 -- --
08/14/2019 Q2 -- -- -$1.54 -- --
03/31/2019 Q1 -- -- -$0.18 -- --
03/31/2018 Q1 -- -- -$0.06 -- --

Stoke Therapeutics, Inc. Earnings Questions

  • How Much did Stoke Therapeutics, Inc. Generate in Revenue Last Quarter?

    Stoke Therapeutics, Inc. reported $10.6M worth of top line sales in its most recent quarter.

  • Did Stoke Therapeutics, Inc. Beat Earnings Last Quarter?

    Stoke Therapeutics, Inc. announced earnings per share of -$0.65 which represents a miss of analyst forecast a -$0.57 per share.

  • Is Stoke Therapeutics, Inc. Profitable?

    Stoke Therapeutics, Inc. reported $9.6M that represents $0.16 per share over the last quarter.

  • What is the Analyst Consensus for Stoke Therapeutics, Inc. EPS Next Year?

    Stoke Therapeutics, Inc.'s earnings are forecast to decrease from -$1.65 per share to -$2.02 per share next year representing a decrease of -97.01%.

  • When is Stoke Therapeutics, Inc.'s Earnings Date?

    Stoke Therapeutics, Inc.'s next earnings date is March 24, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is JetBlue The Best Airline Stock?
Is JetBlue The Best Airline Stock?

Following a general trend of improvement among airline stocks, shares…

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
65
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
61
PLAB alert for Dec 11

Photronics, Inc. [PLAB] is up 6.18% over the past day.

Buy
100
WRBY alert for Dec 11

Warby Parker, Inc. [WRBY] is up 2.23% over the past day.

Buy
77
BRZE alert for Dec 11

Braze, Inc. [BRZE] is down 3.73% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock